Nontoxic amphiphilic carbon dots as promising drug nanocarriers across the blood-brain barrier and inhibitors of β-amyloid

Yiqun Zhou, Piumi Y. Liyanage, Dinesh Devadoss, Linda Rebeca Rios Guevara, Ling Cheng, Regina M. Graham, Hitendra S. Chand, Abdulrahman O. Al-Youbi, Abdulaziz S. Bashammakh, Mohammad S. El-Shahawi, Roger M. Leblanc

Research output: Contribution to journalArticle

Abstract

The blood-brain barrier (BBB) is a main obstacle for drug delivery targeting the central nervous system (CNS) and treating Alzheimer's disease (AD). In order to enhance the efficiency of drug delivery without harming the BBB integrity, nanoparticle-mediated drug delivery has become a popular therapeutic strategy. Carbon dots (CDs) are one of the most promising and novel nanocarriers. In this study, amphiphilic yellow-emissive CDs (Y-CDs) were synthesized with an ultrasonication-mediated methodology using citric acid and o-phenylenediamine with a size of 3 nm that emit an excitation-independent yellow photoluminescence (PL). The content of primary amine and carboxyl groups on CDs was measured as 6.12 × 10-5 and 8.13 × 10-3 mmol mg-1, respectively, indicating the potential for small-molecule drug loading through bioconjugation. Confocal image analyses revealed that Y-CDs crossed the BBB of 5-day old wild-type zebrafish, most probably by passive diffusion due to the amphiphilicity of Y-CDs. And the amphiphilicity and BBB penetration ability didn't change when Y-CDs were coated with different hydrophilic molecules. Furthermore, Y-CDs were observed to enter cells to inhibit the overexpression of human amyloid precursor protein (APP) and β-amyloid (Aβ) which is a major factor responsible for AD pathology. Therefore, data suggest that Y-CDs have a great potential as nontoxic nanocarriers for drug delivery towards the CNS as well as a promising inhibiting agent of Aβ-related pathology of the AD.

Original languageEnglish (US)
Pages (from-to)22387-22397
Number of pages11
JournalNanoscale
Volume11
Issue number46
DOIs
StatePublished - Dec 14 2019

Fingerprint

Drug delivery
Amyloid
Carbon
Neurology
Pathology
Pharmaceutical Preparations
Molecules
Amyloid beta-Protein Precursor
Citric acid
Citric Acid
Amines
Photoluminescence
Nanoparticles
Proteins
Blood-Brain Barrier

ASJC Scopus subject areas

  • Materials Science(all)

Cite this

Nontoxic amphiphilic carbon dots as promising drug nanocarriers across the blood-brain barrier and inhibitors of β-amyloid. / Zhou, Yiqun; Liyanage, Piumi Y.; Devadoss, Dinesh; Rios Guevara, Linda Rebeca; Cheng, Ling; Graham, Regina M.; Chand, Hitendra S.; Al-Youbi, Abdulrahman O.; Bashammakh, Abdulaziz S.; El-Shahawi, Mohammad S.; Leblanc, Roger M.

In: Nanoscale, Vol. 11, No. 46, 14.12.2019, p. 22387-22397.

Research output: Contribution to journalArticle

Zhou, Y, Liyanage, PY, Devadoss, D, Rios Guevara, LR, Cheng, L, Graham, RM, Chand, HS, Al-Youbi, AO, Bashammakh, AS, El-Shahawi, MS & Leblanc, RM 2019, 'Nontoxic amphiphilic carbon dots as promising drug nanocarriers across the blood-brain barrier and inhibitors of β-amyloid', Nanoscale, vol. 11, no. 46, pp. 22387-22397. https://doi.org/10.1039/c9nr08194a
Zhou, Yiqun ; Liyanage, Piumi Y. ; Devadoss, Dinesh ; Rios Guevara, Linda Rebeca ; Cheng, Ling ; Graham, Regina M. ; Chand, Hitendra S. ; Al-Youbi, Abdulrahman O. ; Bashammakh, Abdulaziz S. ; El-Shahawi, Mohammad S. ; Leblanc, Roger M. / Nontoxic amphiphilic carbon dots as promising drug nanocarriers across the blood-brain barrier and inhibitors of β-amyloid. In: Nanoscale. 2019 ; Vol. 11, No. 46. pp. 22387-22397.
@article{07a186d8ea4d4942a3804e5bf1b93355,
title = "Nontoxic amphiphilic carbon dots as promising drug nanocarriers across the blood-brain barrier and inhibitors of β-amyloid",
abstract = "The blood-brain barrier (BBB) is a main obstacle for drug delivery targeting the central nervous system (CNS) and treating Alzheimer's disease (AD). In order to enhance the efficiency of drug delivery without harming the BBB integrity, nanoparticle-mediated drug delivery has become a popular therapeutic strategy. Carbon dots (CDs) are one of the most promising and novel nanocarriers. In this study, amphiphilic yellow-emissive CDs (Y-CDs) were synthesized with an ultrasonication-mediated methodology using citric acid and o-phenylenediamine with a size of 3 nm that emit an excitation-independent yellow photoluminescence (PL). The content of primary amine and carboxyl groups on CDs was measured as 6.12 × 10-5 and 8.13 × 10-3 mmol mg-1, respectively, indicating the potential for small-molecule drug loading through bioconjugation. Confocal image analyses revealed that Y-CDs crossed the BBB of 5-day old wild-type zebrafish, most probably by passive diffusion due to the amphiphilicity of Y-CDs. And the amphiphilicity and BBB penetration ability didn't change when Y-CDs were coated with different hydrophilic molecules. Furthermore, Y-CDs were observed to enter cells to inhibit the overexpression of human amyloid precursor protein (APP) and β-amyloid (Aβ) which is a major factor responsible for AD pathology. Therefore, data suggest that Y-CDs have a great potential as nontoxic nanocarriers for drug delivery towards the CNS as well as a promising inhibiting agent of Aβ-related pathology of the AD.",
author = "Yiqun Zhou and Liyanage, {Piumi Y.} and Dinesh Devadoss and {Rios Guevara}, {Linda Rebeca} and Ling Cheng and Graham, {Regina M.} and Chand, {Hitendra S.} and Al-Youbi, {Abdulrahman O.} and Bashammakh, {Abdulaziz S.} and El-Shahawi, {Mohammad S.} and Leblanc, {Roger M.}",
year = "2019",
month = "12",
day = "14",
doi = "10.1039/c9nr08194a",
language = "English (US)",
volume = "11",
pages = "22387--22397",
journal = "Nanoscale",
issn = "2040-3364",
publisher = "Royal Society of Chemistry",
number = "46",

}

TY - JOUR

T1 - Nontoxic amphiphilic carbon dots as promising drug nanocarriers across the blood-brain barrier and inhibitors of β-amyloid

AU - Zhou, Yiqun

AU - Liyanage, Piumi Y.

AU - Devadoss, Dinesh

AU - Rios Guevara, Linda Rebeca

AU - Cheng, Ling

AU - Graham, Regina M.

AU - Chand, Hitendra S.

AU - Al-Youbi, Abdulrahman O.

AU - Bashammakh, Abdulaziz S.

AU - El-Shahawi, Mohammad S.

AU - Leblanc, Roger M.

PY - 2019/12/14

Y1 - 2019/12/14

N2 - The blood-brain barrier (BBB) is a main obstacle for drug delivery targeting the central nervous system (CNS) and treating Alzheimer's disease (AD). In order to enhance the efficiency of drug delivery without harming the BBB integrity, nanoparticle-mediated drug delivery has become a popular therapeutic strategy. Carbon dots (CDs) are one of the most promising and novel nanocarriers. In this study, amphiphilic yellow-emissive CDs (Y-CDs) were synthesized with an ultrasonication-mediated methodology using citric acid and o-phenylenediamine with a size of 3 nm that emit an excitation-independent yellow photoluminescence (PL). The content of primary amine and carboxyl groups on CDs was measured as 6.12 × 10-5 and 8.13 × 10-3 mmol mg-1, respectively, indicating the potential for small-molecule drug loading through bioconjugation. Confocal image analyses revealed that Y-CDs crossed the BBB of 5-day old wild-type zebrafish, most probably by passive diffusion due to the amphiphilicity of Y-CDs. And the amphiphilicity and BBB penetration ability didn't change when Y-CDs were coated with different hydrophilic molecules. Furthermore, Y-CDs were observed to enter cells to inhibit the overexpression of human amyloid precursor protein (APP) and β-amyloid (Aβ) which is a major factor responsible for AD pathology. Therefore, data suggest that Y-CDs have a great potential as nontoxic nanocarriers for drug delivery towards the CNS as well as a promising inhibiting agent of Aβ-related pathology of the AD.

AB - The blood-brain barrier (BBB) is a main obstacle for drug delivery targeting the central nervous system (CNS) and treating Alzheimer's disease (AD). In order to enhance the efficiency of drug delivery without harming the BBB integrity, nanoparticle-mediated drug delivery has become a popular therapeutic strategy. Carbon dots (CDs) are one of the most promising and novel nanocarriers. In this study, amphiphilic yellow-emissive CDs (Y-CDs) were synthesized with an ultrasonication-mediated methodology using citric acid and o-phenylenediamine with a size of 3 nm that emit an excitation-independent yellow photoluminescence (PL). The content of primary amine and carboxyl groups on CDs was measured as 6.12 × 10-5 and 8.13 × 10-3 mmol mg-1, respectively, indicating the potential for small-molecule drug loading through bioconjugation. Confocal image analyses revealed that Y-CDs crossed the BBB of 5-day old wild-type zebrafish, most probably by passive diffusion due to the amphiphilicity of Y-CDs. And the amphiphilicity and BBB penetration ability didn't change when Y-CDs were coated with different hydrophilic molecules. Furthermore, Y-CDs were observed to enter cells to inhibit the overexpression of human amyloid precursor protein (APP) and β-amyloid (Aβ) which is a major factor responsible for AD pathology. Therefore, data suggest that Y-CDs have a great potential as nontoxic nanocarriers for drug delivery towards the CNS as well as a promising inhibiting agent of Aβ-related pathology of the AD.

UR - http://www.scopus.com/inward/record.url?scp=85075812533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075812533&partnerID=8YFLogxK

U2 - 10.1039/c9nr08194a

DO - 10.1039/c9nr08194a

M3 - Article

C2 - 31730144

AN - SCOPUS:85075812533

VL - 11

SP - 22387

EP - 22397

JO - Nanoscale

JF - Nanoscale

SN - 2040-3364

IS - 46

ER -